Augmenting CAR NK cell Anti-tumor Activity by Synapse Tuning
Peter Chockley(St. Jude Children's Research Hospital), Stephen Gottschalk(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
MyD88/CD40 signaling retains CAR T cells in a less differentiated state
|JCI Insight|2020|64
Synapse-tuned CARs enhance immune cell anti-tumor activity
|Nature Biotechnology|2023|57
Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin
|Cancer Immunology Research|2020|43
BACH2 regulates T cell lineage states to overcome dysfunction driven by tonic CAR signaling
|Research Square|2025|1
Natural Killer Cell Immune Surveillance of Cancer
|Deep Blue (University of Michigan)|2018|0